Scientists compared blood from frequent, long-term donors to that of more seldom ones and saw some key genetic differences in ...

Dr Sanjay Aggarwal - a general physician at Holistic Healthcare Centre in Delhi - recently emphasised, however: "It may be more accurate to say people with type O blood are at a lower risk for ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

Wānaka resident and multiple myeloma blood cancer patient Emma Holden, 36, will soon travel to Shanghai, China for cutting-edge treatment. The CAR T-cell therapy involves the col ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

This cancer-patient dad of three young kids is grateful for a "sci-fi" blood treatment advanced by Vanderbilt and oncologist Dr. Olalekan Oluwole.

Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.

The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...